Monthly Archives: December, 2017
Alosetron Risk Evaluation and Mitigation Strategies Paid Survey for Women Using Alosetron (Lotronex) Opens January 3, 2018
IBS Impact has received this notice directly from Alosetron Risk Evaluation and Mitigation Strategies Program on behalf of the U.S. FDA, and is posting at the program’s request. This is paid survey for women who have taken alosetron (Lotronex) for IBS-D anytime in the last 12 months. The exact text provided to IBS Impact follows …
American Neurogastroenterology and Motility Society Pediatric IBS Twitter Chat, December 20, 2017
The American Neurogastroenterology and Motility Society (ANMS) has announced that it will be holding a Twitter chat from 6:00-7:00 PM Eastern Time tomorrow, Wednesday, December 20, 2017. on the subject of “Irritable bowel syndrome in children. What is it, and what treatments are available?” The chat moderator will be Peter Lu, MD, MS, Assistant Professor …
IBS IMPACT 